Sep 26, 2025 | 2025, Investors, Past Events
During the session, our management team will provide an update on the latest scientific and financial results. To register, please click on the link or contact us at IR@philogen.com for further details.Sep 2, 2025 | 2025, Past Events
Dr. Samuele Cazzamalli is presenting “From DNA-encoded chemistry to ACP3-targeted radioligand therapeutics against prostate cancer”. In addition, Dr. Cristiano Pini will give an update on “Diagnostic Performance, Safety, and Pharmacokinetics of [68Ga]Ga-OncoACP3 in...Jun 25, 2025 | 2025, Events, Investors, Past Events
The Webinar will take place on June 25 at 10:00 ET | 15:00 GMT | 16:00 CET. Please use this link to register to the event or contact us at ir@philogen.comJun 24, 2025 | 2025, Past Events, Press Releases
More detailsJun 11, 2025 | 2025, Events, Investors, Past Events
Following last night’s announcement regarding OncoACP3, we are pleased to invite you to a webinar with Prof. Dario Neri, taking place today, June 11, at 11:00 ET | 17:00 CET. Please contact us at IR@philogen.com or follow the link to register to the...Apr 23, 2025 | 2025, Events, Past Events, Scientific
Claudia Comacchio is presenting a poster about Philochem’s ACP3 antibody therapeutics on April 29, entitled “Generation and in vivo characterization of a novel antibody targeting Prostatic Acid Phosphatase (ACP-3)” [Abstract Number 4781]. Gudrun Thorhallsdottir is...
Recent Comments